ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Approved

Cerebrolysin

Cerebrolysin

Also known as: FPF-1070, Brain Peptide Complex

Overview

Key Facts

Primary Goal: A neuropeptide preparation derived from enzymatic breakdown of purified porcine brain proteins

A neuropeptide preparation derived from enzymatic breakdown of purified porcine brain proteins. Contains a mixture of small peptides and free amino acids with neurotrophic activity, used clinically for stroke and TBI recovery. Half-Life ~30 minutes (active metabolites persist longer) Typical Dose 5–30 mg Frequency 1x daily for 10-20 day cycles Cycle Length 10-20 day infusion cycles, repeated as needed

Dosing Information

Half-Life

~30 minutes (active metabolites persist longer)

Typical Dose

5–30 mg

Frequency

1x daily for 10-20 day cycles

Cycle Length

10-20 day infusion cycles, repeated as needed

Administration Routes:

intramuscularintravenous

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F)
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Research Summary

Approved

Approved in over 40 countries for stroke, TBI, and dementia. Multiple Phase 3 RCTs including the CASTA trial (stroke) and large Alzheimer's studies. Cochrane reviews note some positive signals but call for additional high-quality trials. Manufactured by EVER Neuro Pharma (Austria).

Frequently Asked Questions

Common questions about Cerebrolysin

UK-Specific Information

Exclusive data points and guidance for UK residents using Cerebrolysin

UK Lab Testing

US Lab Testing

Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With